These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17948826)

  • 1. [From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating erectile dysfunction in diabetic men].
    Hamerlynck JV; Middeldorp S; Hooft L
    Ned Tijdschr Geneeskd; 2007 Sep; 151(38):2101-4. PubMed ID: 17948826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
    Vardi M; Nini A
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002187. PubMed ID: 17253475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Berner MM; Kriston L; Harms A
    Int J Impot Res; 2006; 18(3):229-35. PubMed ID: 16239897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
    Yip WC; Chiang HS; Mendoza JB; Tan HM; Li MK; Wang WC; Kopernicky V
    Asian J Androl; 2006 Nov; 8(6):685-92. PubMed ID: 16855765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tadalafil for treatment of erectile dysfunction in men on antidepressants.
    Segraves RT; Lee J; Stevenson R; Walker DJ; Wang WC; Dickson RA
    J Clin Psychopharmacol; 2007 Feb; 27(1):62-6. PubMed ID: 17224715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.
    Paick JS; Choi HK; Kim SC; Ahn TY; Kim JJ; Park JK; Park KS; Lee SW; Kim SW; Park K; Jung H; Park NC
    Asian J Androl; 2008 Sep; 10(5):791-8. PubMed ID: 18645683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phosphodiesterase inhibitor for erectile dysfunction. No less effective in the diabetic patient].
    MMW Fortschr Med; 2002 Jul; 144(29-30):56. PubMed ID: 12219619
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D; Gambla M; Rubio-Aurioles E; Buvat J; Brock GB; Spera G; Rose L; Lording D; Liang S
    Diabet Med; 2008 Feb; 25(2):138-46. PubMed ID: 18290855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
    J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of erectile dysfunction of neurogenic genesis with inhibitors of phosphodiesterase of type 5 in patients with diabetes mellitus].
    Kurbatov DG; Rozhivanov RV
    Urologiia; 2009; (5):48-9. PubMed ID: 20209871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IC351 (tadalafil, Cialis): update on clinical experience.
    Porst H
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S57-64. PubMed ID: 11850737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
    Wong P; Lawrentschuk N; Bolton DM
    Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
    Tan HM; Chin CM; Chua CB; Gatchalian E; Kongkanand A; Moh CL; Ng FC; Ratana-Olarn K; Serrano D; Taher A; Tambi I; Tantiwong A; Chen MW; Yip WC
    Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Rosen RC; Shaw JW
    Int J Impot Res; 2006; 18(6):570-1; author reply 572-3. PubMed ID: 17075585
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.
    Gales BJ; Gales MA
    Ann Pharmacother; 2008 Jan; 42(1):111-5. PubMed ID: 18094344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The safety of tadalafil in the treatment of erectile dysfunction].
    Wang HY; Huang YF
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):762-4. PubMed ID: 17918720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific aspects of erectile dysfunction in endocrinology.
    Miralles-García JM; García-Díez LC
    Int J Impot Res; 2004 Oct; 16 Suppl 2():S10-2. PubMed ID: 15496851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.